HCID 68632008, Verbindung → HCID 57829808, Verbindung
Reaktionsgleichung
CN(C)[CH:3]=[C:4]([C:8]1[O:12][N:11]=[C:10]([CH3:13])[N:9]=1)[C:5](=O)[CH3:6].[N+]([O-])(O)=O.[N+]([O-])(O)=O.[CH3:23][O:24][C:25]1[CH:26]=[C:27]([NH:37][C:38]([NH2:40])=[NH:39])[CH:28]=[CH:29][C:30]=1[N:31]1[CH:35]=[C:34]([CH3:36])[N:33]=[CH:32]1>>[CH3:23][O:24][C:25]1[CH:26]=[C:27]([NH:37][C:38]2[N:40]=[C:5]([CH3:6])[C:4]([C:8]3[O:12][N:11]=[C:10]([CH3:13])[N:9]=3)=[CH:3][N:39]=2)[CH:28]=[CH:29][C:30]=1[N:31]1[CH:35]=[C:34]([CH3:36])[N:33]=[CH:32]1Komponenten
3
Versuchsvorschrift
The title compound was prepared from crude 4-dimethylamino-3-(3-methyl-[1,2,4]oxadiazol-5-yl)-but-3-en-2-one (313 mg, 1.6 mmol) and N-[3-methoxy-4-(4-methyl-imidazol-1-yl)-phenyl]-guanidine dinitrate (297 mg, 0.8 mmol) using in analogous manner the procedure described in example 39b). Obtained as a pale-yellow solid (142 mg, 47%).
Quellen und Nachweise
- ORD-Eintrag
- ord-ea21d87b0e754512a54d9eb9d1a98f22
- Quelldatensatz
- uspto-grants-2015_02